Form 4: Teva Pharmaceutical Industries: Chief Accounting Officer Amir Weiss Reports Share Transactions
SEC Form 4 Filing
Amir Weiss, Chief Accounting Officer of Teva Pharmaceutical Industries, reports the acquisition and disposal of ordinary shares and restricted share units.
Summary
- Amir Weiss, the Chief Accounting Officer of Teva Pharmaceutical Industries, filed a Form 4 detailing changes in beneficial ownership.
- On March 3, 2024, Weiss acquired 5,179 ordinary shares through the vesting of restricted share units and disposed of 19,074 ordinary shares.
- On March 4, 2024, Weiss acquired 10,676 ordinary shares through the vesting of restricted share units and disposed of 29,750 ordinary shares.
- Additionally, on March 4, 2024, Weiss acquired 22,600 restricted share units.
- Following these transactions, Weiss directly owns 15,538 ordinary shares and 22,600 restricted share units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 03/03/2023 | Restricted share units were granted, vesting in installments through March 3, 2027. |
| 03/04/2022 | Restricted share units were granted, vesting in installments through March 4, 2026. |
| 03/03/2024 | Acquisition of 5,179 ordinary shares and disposal of 19,074 ordinary shares. |
| 03/04/2024 | Acquisition of 10,676 ordinary shares, disposal of 29,750 ordinary shares, and grant of 22,600 restricted share units. |
| 03/05/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.